SREDNJI VOLUMEN TROMBOCITA: PREVIDJELI GLASNIK ZLOĆUDNIH ČVOROVA ŠTITNJAČE by Mustafa Sit et al.
Acta Clin Croat 2019; 58:417-420 Original Scientific Paper
doi: 10.20471/acc.2019.58.03.03
Acta Clin Croat, Vol. 58, No. 3, 2019  417
MEAN PLATELET VOLUME: AN OVERLOOKED HERALD 
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SUMMARY – Physicians and surgeons pay much attention to evaluating thyroid nodules due to 
the malignant potential of these growths. Inflammation has a crucial role in the development of can-
cer. Increase in the mean platelet volume (MPV) has been described in various inflammatory con-
ditions. Since some of thyroid nodules are malignant, we aimed to compare MPV values between 
patients with malignant and benign thyroid nodules after precise pathologic diagnosis. We retrospec-
tively analyzed hemograms of patients having undergone thyroid surgery for thyroid nodule between 
January 2013 and January 2015, and compared them to those recorded in healthy subjects. MPV was 
higher in the malignant thyroid nodule group than in the benign nodule group (9.1±1 fL vs. 7.8±0.8 
fL). The difference was statistically significant (p<0.001). Increased MPV should be considered as an 
assistive diagnostic tool in differentiating malignant and benign thyroid nodules. However, further 
prospective studies are required to confirm its usefulness in this population.
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Introduction
Physicians and surgeons pay much attention to 
evaluating thyroid nodules due to the malignant po-
tential of these growths. Women are more likely to 
develop thyroid nodules, and in iodine deficient coun-
tries, its prevalence may reach 5%1. Advances in imag-
ing modalities such as ultrasound scan have increased 
the rate of nodule detection in the gland. The preva-
lence of thyroid nodules on ultrasound may be as high 
as 67%2. Since an important proportion of thyroid 
nodules include malignant cells, clinicians should 
search for possible malignancy, especially in suspected 
nodules. Ultrasound scan and scintigraphy features 
help discriminate these nodules, especially in cases 
with a history of exposure to radiation.
Inflammation has a crucial role in the development 
of cancer3,4. Association between neoplasm and many 
inflammatory markers has been studied recently5. One 
of these markers is the hemogram derived mean plate-
let volume (MPV). It is an index of routine hemogram 
tests and reflects platelet size. Activation of platelets is 
associated with an increase in MPV value6. An increase 
in MPV has been described in various inflammatory 
conditions7-9. Not only inflammatory diseases with a 
high inflammatory burden, but also neoplastic disor-
ders have been associated with MPV. Elevated MPV 
is reported in gastric10 and colon cancer11. Moreover, 
increased MPV has been proposed as a prognostic fac-
tor in critically ill patients12.
Since some of thyroid nodules are malignant, we 
aimed to compare MPV values in patients with malig-




The subjects having undergone surgery for thyroid 
nodule at our surgery departments between January 
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2013 and January 2015 were included in the study. 
Based on pathologic examination of thyroid gland sur-
gical specimens, these patients were divided into two 
groups of malignant nodules and benign nodules. The 
study was approved by the institutional Ethics Com-
mittee. Demographic and laboratory data were ob-
tained from the hospital computerized database. Pre-
operative hemogram values of thyroid nodule patients, 
white blood cell count (WBC), hemoglobin (Hb), 
hematocrit (Htc), mean corpuscular volume (MCV), 
platelet count (PLT), thyroid stimulating hormone 
(TSH) and MPV were recorded.
Active infection, diabetes mellitus, thyroiditis, any 
other type of malignancy, inflammatory diseases were 
set as exclusion criteria. Patients on corticosteroid or 
aspirin treatment were also excluded.
The Beckman Coulter LH 780 autoanalyzer (Beck-
man Coulter Inc., Brea, CA, USA) was used to per-
form hemogram tests. Hemogram and other biochem-
ical and pathological assays were conducted at labora-
tories of our university hospital.
Statistical analysis
Statistical analysis was conducted by use of SPSS 
software (SPSS15.0; SPSS Inc., Chicago, IL, USA). 
Data were expressed as mean ± SD or median (min-
max). Student’s t-test or Mann-Whitney U test was 
used to compare variables between the study groups. 
The level of statistical significance was set at p<0.05.
Results
A total of 199 subjects, 101 patients with malig-
nant and 98 patients with benign thyroid nodules, 
were included in the study. Median age of the malig-
nant and benign thyroid nodule patients was 43 (25-
77) and 45 (26-60) years, respectively. Age was not 
significantly different between malignant and benign 
thyroid nodule groups (p=0.79).
The malignant thyroid nodule group consisted of 
77 women and 24 men, whereas the benign nodule 
group included 75 women and 23 men. Gender distri-
bution was not significantly different between the 
groups (p=0.96).
White blood cell count, Hb, Htc, MCV, PLT and 
TSH levels were not different between the malignant 
thyroid nodule group and benign nodule group (p>0.05 
all). General characteristics and laboratory data of the 
study groups are summarized in Table 1.
The MPV was higher in the malignant thyroid 
nodule group as compared with the benign nodule 
group (9.1±1 fL vs. 7.8±0.8 fL), yielding a statistically 
significant difference (p<0.001).
The receiver operating characteristic curve (ROC) 
analysis was performed to define the sensitivity and 
specificity of MPV in detecting malignant nodules. 
The MPV cut-off value of 8.25 had 81% sensitivity 
and 66% specificity in determining malignant nodules 
(p<0.001; area under the curve (AUC) 0.84; lower 
bound 0.78; upper bound 0.89).
Discussion
The main finding of the present study was that el-
evated MPV might indicate malignancy in patients 
with thyroid nodules. MPV is considered to be associ-
ated with certain malignancies. Elevated MPV values 
have been reported in various types of cancer at the 
time of diagnosis13. Another study reports on increased 
MPV in patients with colon cancer, which was reduced 
after surgery11. Increased MPV has also been reported 
in gastric10and epithelial ovarian tumors14.







Gender Men (n) 24 23 0.96Women (n) 77 75
Mean ± SD
WBC (K/mm3) 6.9±1.7 7.2±1.9 0.13
Hb (g/dL) 13.5±1.2 13.6±1.1 0.79
Htc (%) 40±3.5 40.5±3 0.33
MCV (fL) 86.8±3.7 87.3±4.2 0.34
PLT (K/mm3) 249±63 260±58 0.19
MPV (fL) 9.1±1 7.8±0.8 <0.001
Median (min-max)
Age (years) 43 (25-77) 45 (26-60) 0.79
TSH (uIU/mL) 1.21  (0.01-5.7)
0.93  
(0.01-4.4) 0.60
WBC = white blood cell count; Hb = hemoglobin; Htc = hemato-
crit; MCV = mean corpuscular volume; PLT = platelet count; MPV 
= mean platelet volume; TSH = thyroid stimulating hormone
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We will discuss the rationale for MPV elevation in 
cancer at this point. Inflammation causes an increase 
in the levels of circulating cytokines. These cytokines, 
especially interleukin (IL)-6, may interfere with mega-
karyopoiesis in bone marrow and cause production of 
larger platelets. This may be the underlying reason for 
increased MPV in cancer patients. Cancer is also as-
sociated with chronic inflammation, thus such a causal 
relationship may be present.
Various diagnostic tools are available to differenti-
ate malignant from benign thyroid nodules. Ultraso-
nography characteristics of malignant thyroid nodules, 
vertical rather than horizontal shape, spiculated bor-
ders, hypoechogenicity and microcalcifications all have 
about 40%-48% sensitivity in detecting malignancy15. 
Leenhardt et al. report on sonography sensitivity and 
specificity for thyroid nodule malignancy of 75% and 
61%, respectively16.
Cold thyroid nodules on thyroid scintigraphy re-
quire further evaluation for suspicious malignancy. 
However, Kountakis et al. report that only 27.5% of 
hypofunctional (cold) thyroid nodules were malignant 
on scintigraphy17. Although hot nodules in scintigra-
phy are considered almost always benign18, malignancy 
was detected in 6% of hyper functioning hot nodules17. 
Diagnostic accuracy of a combination of sonography 
and scintigraphy is not excellent either. Only about 
35% of sonographic solid and scintigraphically cold 
nodules were reported as malignant by fine needle as-
piration cytology (FNAC)19.
In our study, the sensitivity and specificity of MPV 
at a threshold of 8.25 were better than by ultrasound 
and scintigraphy.
Fine needle aspiration cytology of thyroid nodule, 
which is considered as the most important method for 
detecting malignancy in thyroid nodules, has a sensi-
tivity of 91% in selecting malignant nodules20. How-
ever, the rate of false-negative and false-positive results 
of FNAC can be as high as 11% and 7%, respectively18. 
Owing to higher sensitivity and specificity of MPV at 
8.25 threshold, we think that it can be used in combi-
nation with sonography, scintigraphy and FNAC to 
establish the nature of thyroid nodules. Such a combi-
nation not only increases diagnostic accuracy, but also 
may improve the cost-effectiveness by reducing re-
peated expensive techniques (FNAC, etc.) in cases of 
non-diagnostic test results.
Not only thyroid disease but also metabolic altera-
tion such as obesity, type 2 diabetes mellitus and dia-
betic nephropathy were associated with MPV levels in 
hemogram tests21,22.
There were several limitations to the present study. 
First, the retrospective design made our results diffi-
cult to interpret. Another limitation was the relatively 
small study population. Finally, we did not compare 
sonography, cytology and scintigraphy test results of 
the study population with MPV, which should be the 
subject of another study in the near future.
In conclusion, increased MPV should be consid-
ered as an assistive diagnostic tool in differentiating 
malignant and benign thyroid nodules. However, fur-
ther prospective studies are required to confirm its use-
fulness in this population.
References
 1. Tunbridge W, Evered D, Hall R, Appleton D, Brewis M, Clark 
F, et al. The spectrum of thyroid disease in a community: the 
Whickham survey. Clin Endocrinol. 1977;7(6):481-93. DOI: 
10.1111/j.1365-2265.1977.tb01340.x
 2. Ezzat S, Sarti DA, Cain DR, Braunstein GD. Thyroid inci-
dentalomas: prevalence by palpation and ultrasonography. 
Arch Int Med. 1994;154(16):1838-40. DOI: 10.1001/
archinte.154.16.1838
 3. Coussens LM, Werb Z. Inflammation and cancer. Nature. 
2002;420(6917):860-7. DOI: 10.1038/nature01322
 4. Grivennikov SI, Greten FR, Karin M. Immunity, inflamma-
tion, and cancer. Cell. 2010;140(6):883-99. DOI: 10.1016/j.
cell.2010.01.025
 5. Solak Mekić M, Pedišić I, Šobat H, Vučićević Boras V, Kirac I, 
Štefančić L, et al. The role of complete blood count parameters 
in patients with colorectal cancer. Acta Clin Croat. 2018 
Dec;57(4):624-9. DOI: 10.20471/acc.2018.57.04.03
 6. Park Y, Schoene N, Harris W. Mean platelet volume as an in-
dicator of platelet activation: methodological issues. Platelets. 
2002;13(5-6):301-6. DOI: 10.1080/095371002220148332
 7. Kapsoritakis AN, Koukourakis MI, Sfiridaki A, Potamianos 
SP, Kosmadaki MG, Koutroubakis IE, et al. Mean platelet vol-
ume: a useful marker of inflammatory bowel disease activity. 
Am J Gastroenterol. 2001;96(3):776-81. DOI: 10.1111/ 
j.1572-0241.2001.03621.x
 8. Ceylan B, Fincanci M, Yardimci C, Eren G, Tözalgan Ü, 
Müderrisoglu C, et al. Can mean platelet volume determine the 
severity of liver fibrosis or inflammation in patients with chro-
nic hepatitis B? Eur J Gastroenterol Hepatol. 2013;25(5): 
606-12. DOI: 10.1097/MEG.0b013e32835d08da
 9. Polińska B, Matowicka-Karna J, Kemona H. Assessment of the 
influence of the inflammatory process on the activation of 
blood platelets and morphological parameters in patients with 
ulcerative colitis (colitis ulcerosa). Folia Histochem Cytobiol. 
2011;49(1):119-24.
M. Sit et al. Mean platelet volume in thyroid nodules
420 Acta Clin Croat, Vol. 58, No. 3, 2019
10. Kılıncalp S, Ekiz F, Basar O, Ayte MR, Coban S, Yılmaz B, et 
al. Mean platelet volume could be possible biomarker in early 
diagnosis and monitoring of gastric cancer. Platelets. 2014; 
25(8):592-4. DOI: 10.3109/09537104.2013.783689
11. Li J-Y, Li Y, Jiang Z, Wang R-T, Wang X-S. Elevated mean 
platelet volume is associated with presence of colon cancer. 
Asian Pac J Cancer Prev. 2014;15(23):10501-4. DOI: 10.7314/
apjcp.2014.15.23.10501
12. Karagoz I, Aktas G, Yoldas H, Yildiz I, Ogun MN, Bilgi M, et 
al. Association between hemogram parameters and survival of 
critically ill patients. J Intensive Care Med. 2019;34(6):511-3. 
DOI: 10.1177/0885066617703348
13. Mutlu H, Artis TA, Erden A, Akca Z. Alteration in mean 
platelet volume and platicrit values in patients with cancer that 
developed thrombosis. Clin Appl Thromb Hemost. 2013; 
19(3):331-3. DOI: 10.1177/1076029611433644
14. Kemal Y, Demirag G, Ekiz K, Yucel I. Mean platelet volume 
could be a useful biomarker for monitoring epithelial ovarian 
cancer. J Obstet Gynaecol. 2014;34(6):515-8. DOI: 10.3109/ 
01443615.2014.912620
15. Moon W-J, Jung SL, Lee JH, Na DG, Baek J-H, Lee YH, et al. 
Benign and malignant thyroid nodules: US differentiation – 
multicenter retrospective study. Radiology. 2008;247(3):762-
70. DOI: 10.1148/radiol.2473070944
16. Leenhardt L, Tramalloni J, Aurengo H, Delbot T, Guillausseau 
C, Aurengo A. Echographie des nodules thyroïdiens: l’écho-
graphiste face aux exigences du clinicien. Presse Med. 1994; 
23(30):1389-92.
17. Kountakis SE, Skoulas IG, Maillard A. The radiologic work-up 
in thyroid surgery: fine-needle biopsy versus scintigraphy and 
ultrasound. Ear Nose Throat J. 2002;81(3):151-4.
18. Maia FF, Zantut-Wittmann DE. Thyroid nodule management: 
clinical, ultrasound and cytopathological parameters for pre-
dicting malignancy. Clinics. 2012;67(8):945-54.
19. Fariduddin M, Amin A, Ahmed M, Karim S, Moslem F, Ka-
mal M. Malignancy in solitary solid cold thyroid nodule. My-
mensingh Med J. 2012 Apr;21(2):276-80.
20. Danese D, Sciacchitano S, Farsetti A, Andreoli M, Pontecorvi 
A. Diagnostic accuracy of conventional versus sonography-
guided fine-needle aspiration biopsy of thyroid nodules. Thy-
roid. 1998;8(1):15-21. DOI: 10.1089/thy.1998.8.15
21. Aktas G, Kocak MZ, Duman TT, Erkus E, Atak BM, Sit M, et 
al. Mean platelet volume (MPV) as an inflammatory marker 
in type 2 diabetes mellitus and obesity. Bali Med J. 2018;7(3): 
650-3. DOI:10.15562/bmj.v7i3.806
22. Kocak MZ, Aktas G, Erkus E, Duman TT, Atak BM, Savli H. 
Mean platelet volume to lymphocyte ratio as a novel marker for 
diabetic nephropathy. J Coll Physicians Surg Pak. 2018 Nov;28 
(11):844-7. DOI: 10.29271/jcpsp.2018.11.844
Sažetak
SREDNJI VOLUMEN TROMBOCITA: PREVIDJELI GLASNIK ZLOĆUDNIH ČVOROVA ŠTITNJAČE
M. Sit, G. Aktas, B. Ozer, M. Z. Kocak, E. Erkus, H. Erkol, S. Yaman i H. Savli
Liječnici i kirurzi pridaju veliku pozornost procjeni čvorova štitne žlijezde zbog malignog potencijala ovih novotvorina. 
Upala ima ključnu ulogu u razvoju raka. Povećani srednji volumen trombocita (mean platelet volume, MPV) opisuje se u raz-
nim upalnim stanjima. Kako su neki od čvorova štitne žlijezde zloćudni cilj nam je bio usporediti vrijednosti MPV između 
bolesnika sa zloćudnim i dobroćudnim čvorovima štitnjače nakon precizne patološke dijagnoze. Retrospektivno su analizi-
rani hemogrami bolesnika podvrgnutih operaciji štitne žlijezde zbog čvorova od siječnja 2013. do siječnja 2015. godine te 
uspoređeni s vrijednostima dobivenim u zdravih osoba. MPV je bio viši u skupini zloćudnih tireoidnih čvorova nego u sku-
pini dobroćudnih čvorova (9,1±1 fL prema 7,8±0,8 fL), a razlika je bila statistički značajna (p<0,001). Povišeni MPV može 
se smatrati pomoćnim dijagnostičkim alatom u razlikovanju zloćudnih i dobroćudnih čvorova štitnjače. Međutim, potrebna 
su daljnja istraživanja kako bi se potvrdila njegova korist kod ove populacije.
Ključne riječi: Tireoideja, čvor; Neoplazme; Upala: Prosječni volumen trombocita; Krvna slika
